Detalhe da pesquisa
1.
Phase 2 study of the safety and efficacy of umbralisib in patients with CLL who are intolerant to BTK or PI3Kδ inhibitor therapy.
Blood
; 137(20): 2817-2826, 2021 05 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33259589
2.
Outcomes of COVID-19 in patients with CLL: a multicenter international experience.
Blood
; 136(10): 1134-1143, 2020 09 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32688395
3.
Phase 1-2 study of vorinostat (SAHA), cladribine and rituximab (SCR) in relapsed B-cell non-Hodgkin lymphoma and previously untreated mantle cell lymphoma.
Br J Haematol
; 186(6): 845-854, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31177537
4.
Outcomes of CLL patients treated with sequential kinase inhibitor therapy: a real world experience.
Blood
; 128(18): 2199-2205, 2016 11 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27601462
5.
COVID-19 in patients with CLL: improved survival outcomes and update on management strategies.
Blood
; 138(18): 1768-1773, 2021 11 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34297826
6.
Toxicities and outcomes of 616 ibrutinib-treated patients in the United States: a real-world analysis.
Haematologica
; 103(5): 874-879, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29419429
7.
Real-world outcomes and management strategies for venetoclax-treated chronic lymphocytic leukemia patients in the United States.
Haematologica
; 103(9): 1511-1517, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29880613
8.
Outcomes of front-line ibrutinib treated CLL patients excluded from landmark clinical trial.
Am J Hematol
; 93(11): 1394-1401, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30132965
9.
Primary myelofibrosis and its targeted therapy.
Ann Hematol
; 96(4): 531-535, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-27539616
10.
Impact of ruxolitinib on myelofibrosis patients post allogeneic stem cell transplant-a pilot study.
Br J Haematol
; 186(5): e130-e133, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31115038
11.
Novel agents and evolving strategies in myelofibrotive neoplasm: an update from 2022 ASH annual conference.
J Hematol Oncol
; 16(1): 53, 2023 05 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37173704
12.
Preclinical evaluation of CD70-specific CAR T cells targeting acute myeloid leukemia.
Front Immunol
; 14: 1093750, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36845088
13.
Acute myeloid leukemia cells and MSC-derived exosomes inhibiting transformation in myelodysplastic syndrome.
Discov Oncol
; 14(1): 115, 2023 Jun 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37382733
14.
The impacts of total body irradiation on umbilical cord blood hematopoietic stem cell transplantation.
Ther Adv Hematol
; 14: 20406207231170708, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37151808
15.
A simple prognostic system in patients with myelofibrosis undergoing allogeneic stem cell transplantation: a CIBMTR/EBMT analysis.
Blood Adv
; 7(15): 3993-4002, 2023 08 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37134306
16.
The small population of PIG-A mutant cells in myelodysplastic syndromes do not arise from multipotent hematopoietic stem cells.
Haematologica
; 97(8): 1225-33, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22315493
17.
Immunocompetent Patient With Primary Bone Marrow Hodgkin Lymphoma.
J Med Cases
; 13(9): 427-431, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-36258707
18.
Mantle cell lymphoma management trends and novel agents: where are we going?
Ther Adv Hematol
; 13: 20406207221080743, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35237397
19.
The role of adjuvant chemotherapy in the management of acute promyelocytic leukemia differentiation syndrome.
Front Oncol
; 12: 911745, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35992790
20.
Combined epigenetic and immunotherapy for blastic and classical mantle cell lymphoma.
Oncotarget
; 13: 986-1002, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36093297